MedPath

Comparative Evaluation of Collagen Sponge with recombinant bone morphogenic protein 2 for Alveolar Ridge Preservation: A Pilot Clinical Study

Phase 3
Completed
Conditions
Enrolled the healthy patient who need to extract the single-tooth extraction in the premolar tooth due to unrestorable (caries, fracture, or orthodontic treatment) with an intact buccal bone plate (more than 50%)
Alveolar ridge preservation, rhBMP-2, Collagen.
Registration Number
TCTR20240715009
Lead Sponsor
Thailand Science Research and Innovation (TSRI), and National Science, Research and Innovation Fund (NSRF)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
14
Inclusion Criteria

The healthy patient who need to extract the single-tooth extraction in the premolar tooth due to unrestorable (caries, fracture, or orthodontic treatment) with an intact buccal bone plate (more than 50%
Healthy adults patient (20 years or older) and able to sign an informed consent form.
All extraction sites have a keratinized gingival tissue in a minimum width of 2 mm

Exclusion Criteria

Presence of periodontal disease.
History of smoking, radiotherapy, or chemotherapy within the past 5 years
Pregnancy or breastfeeding.
Previous or current medication e.g. steroids, antiresorptive drugs including affecting on bone remodelling phase.
General contraindications for surgical treatment including antiplatelet or anticoagulation drugs.
Allergy to collagen

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bone reduction 12 weeks Mean difference bone reduction
Secondary Outcome Measures
NameTimeMethod
Clinical evaluation 12 weeks Soft tissue healing
© Copyright 2025. All Rights Reserved by MedPath